
At a Glance
540 Pages
23.5 x 15.88 x 2.54
Hardcover
$809.01
or 4 interest-free payments of $202.25 with
 orÂShips in 5 to 7 business days
| Electrophysiological Pharmacology of Mesencephalic Dopaminergic Neurons | p. 1 |
| Introduction | p. 1 |
| Anatomical Organization | p. 2 |
| Basic Electrophysiological Properties | p. 4 |
| Extracellular Recordings | p. 4 |
| Intracellular Recordings | p. 7 |
| Afferents to Dopaminergic Neurons | p. 8 |
| GABAergic Afferents | p. 8 |
| Glutamatergic Afferents | p. 14 |
| Cholinergic Afferents | p. 19 |
| Monoaminergic Afferents | p. 20 |
| Autoreceptor-Mediated Effects on Dopaminergic Neurons | p. 22 |
| Somatodendritic Autoreceptors | p. 22 |
| Axon Terminal Autoreceptors | p. 24 |
| Are D(2) Autoreceptors Different from Other D(2) Receptors? | p. 25 |
| Are Autoreceptors Ubiquitous Among Dopaminergic Neurons? | p. 26 |
| What Are the Physiological Roles of Autoreceptors? | p. 28 |
| Miscellaneous Neuropharmacology | p. 31 |
| Gamma-Hydroxybutyric Acid | p. 31 |
| Glycine | p. 31 |
| Neuropeptides | p. 31 |
| Acute and Chronic Effects of Antipsychotics on Dopaminergic Neurons | p. 33 |
| Differences Between Effects of Typical and Atypical Antipsychotics | p. 33 |
| Effects of Chronic Antipsychotic Drug Administration -The Depolarization Block Hypothesis | p. 34 |
| Dopaminergic Neurons and Drugs of Abuse: Acute and Chronic Studies | p. 36 |
| Acute Effects of Drugs of Abuse on Dopaminergic Neurons | p. 36 |
| Chronic Effects of Drugs of Abuse on Dopaminergic Neurons | p. 38 |
| Withdrawal Following Chronic Administration | p. 40 |
| Conclusions | p. 42 |
| References | p. 43 |
| Presynaptic Regulation of Dopamine Release | p. 63 |
| Introduction | p. 63 |
| Interactions Between Heteroreceptors or Heteroreceptors and D(2) Autoreceptors Present on Dopaminergic Nerve Terminals | p. 64 |
| Role of Diffusible Messengers in the Presynaptic Control of Striatal Dopaminergic Transmission | p. 67 |
| Local Circuits Involved in the Control of DA Transmission in Striatal Compartments | p. 70 |
| Similarities and Differences in the Presynaptic Regulation of DA Release in Striatal Compartments | p. 72 |
| The GABA- and Dynorphin-Dependent Inhibitions of DA Transmission Triggered by Acetylcholine Occur in Two Distinct Matrix Territories | p. 73 |
| NMDA-Dependent Local Inhibitory Circuits of DA Transmission Occur in Both Striatal Compartments and Involve Gabaand Dynorphin | p. 74 |
| Facilitation by DA of the NMDA-Sensitive Local Inhibitory Circuits Involved in the Presynaptic Regulation of DA Release in Striatal Compartments | p. 74 |
| Conclusions | p. 78 |
| References | p. 78 |
| Dopamine - Acetylcholine Interactions | p. 85 |
| Introduction | p. 85 |
| Dopamine - Acetylcholine Interactions in the Basal Ganglia | p. 85 |
| Early Studies | p. 86 |
| Direct D(1) Receptor-Mediated Facilitation of Striatal Acetylcholine Transmission | p. 89 |
| Separate Transduction Pathways for D(1) and D(2) Receptor-Mediated Influences on AcetylcholineTransmission | p. 92 |
| Independent Gating of Input to Striatal Acetylcholine Neurons by Dopamine Receptor Subtypes | p. 92 |
| Relative Role of D(1) and D(2) Receptors in the Control of Striatal Acetylcholine Function | p. 95 |
| Nicotinic Receptors and Dopamine Neurons | p. 98 |
| Actions of Nicotine on Dopamine Function | p. 98 |
| Mechanism of Nicotine Actions on Dopamine Function | p. 100 |
| Dopamine - Acetylcholine Interactions Outside the Basal Ganglia | p. 103 |
| Dopaminergic Regulation of Cortical and Hippocampal Acetylcholine Transmission | p. 104 |
| References | p. 105 |
| Dopamine - Glutamate Interactions | p. 117 |
| Introduction | p. 117 |
| Neuropharmacological Interactions | p. 117 |
| Dopamine and Glutamate Act Within the Same Neuronal Circuits | p. 117 |
| Dopamine and Glutamate Receptors in the Striatum | p. 118 |
| Reciprocal Release Regulation of Dopamine and Glutamate by Dopamine Receptors and IonotropicGlutamate Receptors | p. 119 |
| Reciprocal Regulation of Receptor Synthesis | p. 120 |
| Glutamate Regulates the Synthesis of Dopamine in Striatal Synaptosomes | p. 120 |
| Glutamate and Dopamine Are Co-released from Dopamine Neurons | p. 121 |
| Intraneuronal Interactions | p. 121 |
| Dopamine Receptors and NMDA Receptors Cooperatively Modulate Gene Expression | p. 121 |
| Electrophysiological Interactions | p. 122 |
| Striatal Organization | p. 122 |
| Dopamine Modulates Glutamate Inputs | p. 124 |
| Interaction of the Dopamine and Glutamate Neurotransmitter Systems in Other Brain Areas | p. 126 |
| Functional Consequences of the Interaction of the Glutamate and Dopamine Systems | p. 127 |
| References | p. 128 |
| Dopamine - Adenosine Interactions | p. 135 |
| Adenosine in the CNS | p. 135 |
| Receptor Distribution | p. 135 |
| Adenosine in CNS Pathology | p. 137 |
| Pharmacology of Adenosine Receptors | p. 138 |
| Adenosine - Dopamine Interactions | p. 139 |
| Dopamine D(1) and Adenosine Receptors | p. 140 |
| Dopamine D(2) and Adenosine Receptors | p. 141 |
| Modulation of Dopamine Release | p. 143 |
| Therapeutic Implications | p. 144 |
| References | p. 145 |
| Dopamine - GabaInteractions | p. 151 |
| Introduction | p. 151 |
| The Anatomical Relationship Between Nigrostriatal Dopamine and GabAergic Neurons | p. 151 |
| Substantia Nigra | p. 151 |
| Striatum | p. 152 |
| Other Basal Ganglia Regions | p. 152 |
| Functional Interactions Between Gabaand Nigrostriatal Dopaminergic Neurons | p. 153 |
| Striatum | p. 153 |
| Effects of Gabaon Dopaminergic Neurons | p. 153 |
| Effects of Dopamine on GABAergic Output Neurons | p. 153 |
| Dopaminergic Regulation of Striatal GABAergic Interneurons | p. 155 |
| Dopaminergic Regulation of Striatal GabaRelease | p. 155 |
| Dopamine - GabaInteractions in the Globus Pallidus | p. 156 |
| Gaba- DA Interactions in the Internal Pallidum | p. 158 |
| DA - GabaInteractions in the Substantia Nigra | p. 159 |
| Functional Implications of Gaba- DA Interactions Within the Basal Ganglia | p. 160 |
| DA - GabaInteractions in the Mesolimbic Pathway | p. 161 |
| DA - GabaInteractions in the Mesocortical System | p. 163 |
| References | p. 165 |
| Dopamine - Its Role in Behaviour and Cognition in Experimental Animals and Humans | p. 173 |
| Introduction | p. 173 |
| Electrophysiological and Neurocomputational Approaches | p. 174 |
| Neuropharmacological Evidence for a Role for Dopamine in Learning | p. 176 |
| Overview of Results from In Vivo Monitoring Studies | p. 176 |
| Psychopharmacological Evidence of Specific Actions of Dopamine on Learning and Memory | p. 178 |
| The Possible Complication of a Role for Dopamine in Attentional Function | p. 182 |
| Models of ADHD | p. 185 |
| Working Memory | p. 186 |
| Problems of Interpretation of the Role of the PFC in Working Memory | p. 190 |
| Evidence for a Role for Dopamine in Cognition in Humans | p. 192 |
| Dopamine and Cognition in Clinical Disorders: Parkinson's Disease, Schizophrenia, Acute Brain Injury and ADHD | p. 193 |
| Effects of Dopaminergic Drugs on Cognition in Normal Human Volunteers | p. 196 |
| Conclusions and Future Directions | p. 199 |
| References | p. 203 |
| Molecular Knockout Approach to the Study of Brain Dopamine Function | p. 213 |
| Introduction | p. 213 |
| Limitations of the Knockout Approach: Compensation and Epistasis | p. 216 |
| Overview of the Midbrain Dopamine System in Motor Behavior and Reward | p. 218 |
| Overview of the Dopamine Receptor Subtypes in Motor Behavior and Reward | p. 219 |
| D(1) Receptor Knockouts | p. 220 |
| D(2) Receptor Knockouts | p. 222 |
| D(3) Receptor Knockouts | p. 224 |
| Knockout of the Dopamine Transporter | p. 225 |
| Knockout of Tyrosine Hydroxylase Gene | p. 227 |
| Other Knockouts | p. 229 |
| Summary and Conclusions: What We Know That We Did Not Know Before Knockouts | p. 231 |
| References | p. 232 |
| Behavioural Pharmacology of Dopamine D(2) and D(3) Receptors: Use of the Knock-out Mice Approach | p. 239 |
| Introduction | p. 239 |
| Behavioural Pharmacology of DA D(2)/D(3) Receptor Agonists | p. 240 |
| Correlational Studies Using DA D(2)/D(3) Receptor Agonists | p. 241 |
| Behavioural Pharmacology of DA D(2)/D(3) Receptor Antagonists | p. 242 |
| Dopamine D(3) Receptor Knock-out Mice | p. 245 |
| Analysis of the Phenotype of D(3) Receptor Knock-out Mice | p. 246 |
| Effects of DA Receptor Ligands in D(3) Receptor Knock-out Mice | p. 246 |
| DA D(2)/D(3) Receptor Agonists | p. 247 |
| DA D(2)/D(3) Receptor Antagonists | p. 247 |
| Psychostimulants | p. 247 |
| Dopamine D(2) Receptor Knock-out Mice | p. 247 |
| Analysis of the Phenotype of D(2) Receptor Knock-out Mice | p. 248 |
| Effects of DA Receptor Ligands in D(2) Receptor Knock-out Mice | p. 248 |
| DA D(2)/D(3) Receptor Agonists | p. 249 |
| DA D(2)/D(3) Receptor Antagonists | p. 249 |
| Psychotropic Agents | p. 249 |
| Direct Comparison Between D(2) and D(3) Receptor Knock-out Mice | p. 250 |
| Comparison of Avoidance Behaviour of D(2) and D(3) Receptor Knock-out Mice | p. 251 |
| Comparison of Effects of DA Receptor Ligands in D(2) and D(3) Receptor Knock-out Mice | p. 252 |
| Psychotropic Agents | p. 252 |
| DA Receptor Antagonists | p. 255 |
| Conclusions | p. 256 |
| References | p. 257 |
| Dopamine and Reward | p. 265 |
| Introduction | p. 265 |
| Terminology | p. 266 |
| Reward, Reinforcer, Incentive | p. 267 |
| Motivation and Instrumental Responding | p. 268 |
| Incentive-Motivational Responding | p. 269 |
| Instrumental Responding | p. 270 |
| Early Studies: The Original and the Revised Anhedonia Hypothesis | p. 272 |
| Testing the Original Anhedonia Hypothesis | p. 274 |
| Sweet Reward | p. 274 |
| Operant Responding for Sweet Reward | p. 280 |
| The Motor Deficit Issue | p. 281 |
| Response-Reinforcement Functions | p. 285 |
| Reward Summation Studies | p. 285 |
| Intensity-Threshold Studies | p. 286 |
| Response-Reinforcement Matching Studies | p. 287 |
| Dissociating Reinforcement from Incentive-Motivation and Performance | p. 289 |
| Incentive Accounts of the Role of Dopamine in Behaviour | p. 291 |
| Stimulus-Bound Incentive Role of Dopamine? | p. 293 |
| Dopamine and Incentive Arousal | p. 294 |
| Incentive Role of Drug-Stimulated Dopamine Transmission | p. 295 |
| Associative Learning Accounts | p. 296 |
| Pavlovian Incentive Learning | p. 296 |
| Place-Conditioning Studies | p. 301 |
| An Interpretative Framework of the Role of Dopamine in Reward | p. 304 |
| References | p. 309 |
| Molecular and Cellular Events Regulating Dopamine Neuron Survival | p. 321 |
| Introduction | p. 321 |
| Mechanisms of DA Cell Death | p. 322 |
| Extraneuronal Events | p. 323 |
| Noradrenergic System | p. 323 |
| NE in Experimental Parkinsonism | p. 325 |
| Excitatory Amino Acids | p. 327 |
| Excitotoxicity in PD | p. 327 |
| Excitotoxicity in Experimental Parkinsonism | p. 329 |
| The MPTP Model | p. 329 |
| Species Differences in MPTP Toxicity | p. 331 |
| MPP(+) Kinetics | p. 332 |
| Excitotoxicity in the MPTP Model | p. 335 |
| Methamphetamine Toxicity | p. 336 |
| 6-OHDA Toxicity | p. 337 |
| Conclusions on Excitotoxicity | p. 339 |
| Neurotrophic Factors | p. 340 |
| Intraneuronal Events | p. 343 |
| Oxidative Stress | p. 343 |
| Nitric Oxide | p. 345 |
| Apoptosis and Mitochondria | p. 346 |
| Cytochrome P450 System | p. 347 |
| Cytochrome P450 in the CNS | p. 348 |
| P450 System and DA Neurons | p. 349 |
| CYP 2D6 | p. 350 |
| CYP 2E1 | p. 351 |
| The P450 System in PD | p. 351 |
| P450 in Experimental Parkinsonism | p. 353 |
| Toxicity of Dopamine | p. 355 |
| DA and Apoptosis | p. 358 |
| Conclusions About the Pathogenesis of PD | p. 359 |
| References | p. 362 |
| Dopamine and Depression | p. 387 |
| Introduction | p. 387 |
| DA Function in Affective Disorders | p. 389 |
| DA Turnover | p. 389 |
| DA Receptors | p. 391 |
| Neuroendocrine Studies | p. 392 |
| Summary | p. 393 |
| Mood Effects of DA Agonists and Antagonists | p. 393 |
| Psychostimulants | p. 393 |
| DA-Active Antidepressants | p. 394 |
| Neuroleptic-Induced Depression | p. 396 |
| Parkinson's Disease | p. 397 |
| Neuroleptics as Antidepressants | p. 397 |
| Summary | p. 399 |
| Dopaminergic Consequences of Antidepressant Treatment | p. 399 |
| DA autoreceptor Desensitization | p. 399 |
| Sensitization of D(2)/D(3) Receptors | p. 400 |
| Clinical Evidence | p. 401 |
| Summary | p. 402 |
| Dopaminergic Mechanisms in Animal Models of Depression | p. 402 |
| D(2)/D(3) Receptor Sensitization as a Mechanism of Antidepressant Action | p. 402 |
| Clinical Evidence | p. 404 |
| Reciprocal Changes in DA Responses to Reward and Stress | p. 404 |
| Summary | p. 405 |
| Conclusions | p. 406 |
| Limitations of the Dopamine Hypothesis | p. 406 |
| Syndromes or Symptoms? | p. 407 |
| The Wider Picture | p. 408 |
| References | p. 409 |
| Dopamine in Schizophrenia Dysfunctional Information Processing in Basal Ganglia -Thalamocortical Split Circuits | p. 417 |
| The Dopamine Hypothesis of Schizophrenia | p. 417 |
| Schizophrenia as a Dopamine-Dependent Dysfunctional Information Processing in Basal Ganglia - Thalamocortical Circuits | p. 423 |
| Circuit Models of Schizophrenia | p. 425 |
| The Split Circuit Model of Schizophrenia | p. 428 |
| Striatum as a Contention Scheduling Device | p. 430 |
| The Interaction Between the Striatum and the Frontal Cortex | p. 432 |
| Contention Scheduling of Goals by the Limbic Striatum | p. 433 |
| The Role of Tonic and Phasic DA in the Contention Scheduling of Goals | p. 433 |
| Tonic and Phasic DA Release | p. 434 |
| The Establishment of Goals in the Limbic Striatum | p. 436 |
| Goal Selection | p. 436 |
| Goal Maintenance and Energizing | p. 437 |
| Switching Between Goals | p. 438 |
| The Translation of Goals to Behavior | p. 439 |
| Schizophrenia | p. 440 |
| Fronto-temporo-limbic Cortical Dysfunction and Dysregulation of Tonic and Phasic DA Transmission in Schizophrenia | p. 442 |
| The Consequences of Fronto-temporo-limbic Cortical Dysfunction: Disrupted Establishment of Goals | p. 442 |
| The Consequences of Dysregulation of the DA Input to the Limbic Striatum | p. 444 |
| Reduced Tonic DA: Goal Selection, Activation and Maintenance | p. 444 |
| Abnormal Phasic DA Release: Learning and Switching | p. 446 |
| Summary: Phasic and Tonic DA Dysregulation and Schizophrenia Symptoms | p. 449 |
| References | p. 451 |
| Atypical Antipsychotics | p. 473 |
| Introduction | p. 473 |
| Receptor Binding Profile of Antipsychotics | p. 474 |
| Interaction with Dopamine Receptors | p. 481 |
| Interaction with 5-HT(2) and Other 5-HT Receptors | p. 483 |
| Interaction with Various Biogenic Amine Receptors | p. 484 |
| Future Antipsychotics | p. 485 |
| Conclusions | p. 486 |
| Abbreviations | p. 487 |
| References | p. 487 |
| Sleep and Wake Cycle | p. 491 |
| Introduction | p. 491 |
| Dopaminergic Action in Sleep | p. 492 |
| D(2) Antagonists | p. 492 |
| D(2) Agonists | p. 493 |
| D(1) Antagonists | p. 494 |
| D(1) Agonists | p. 494 |
| More Specific Studies | p. 494 |
| Catecholaminergic Pathway Modulation | p. 495 |
| Temperature Regulation | p. 495 |
| Pharmacological Interactions | p. 496 |
| Serotonin | p. 496 |
| Adrenergic System | p. 497 |
| Acetylcholine | p. 498 |
| Histamine | p. 498 |
| H(1) Receptor | p. 499 |
| H(2) Receptor | p. 499 |
| H(3) Receptor | p. 499 |
| GABAergic System | p. 499 |
| Summary | p. 500 |
| References | p. 501 |
| Subject Index | p. 507 |
| Table of Contents provided by Publisher. All Rights Reserved. |
ISBN: 9783540427209
ISBN-10: 3540427201
Series: Handbook of Experimental Pharmacology : Book 2
Published: 27th June 2002
Format: Hardcover
Language: English
Number of Pages: 540
Audience: General Adult
Publisher: Springer Nature B.V.
Country of Publication: DE
Dimensions (cm): 23.5 x 15.88 x 2.54
Weight (kg): 0.89
Shipping
| Standard Shipping | Express Shipping | |
|---|---|---|
| Metro postcodes: | $9.99 | $14.95 |
| Regional postcodes: | $9.99 | $14.95 |
| Rural postcodes: | $9.99 | $14.95 |
Orders over $89.00 qualify for free shipping.
How to return your order
At Booktopia, we offer hassle-free returns in accordance with our returns policy. If you wish to return an item, please get in touch with Booktopia Customer Care.
Additional postage charges may be applicable.
Defective items
If there is a problem with any of the items received for your order then the Booktopia Customer Care team is ready to assist you.
For more info please visit our Help Centre.
You Can Find This Book In

Epigenetics Revolution
How Modern Biology is Rewriting Our Understanding of Genetics, Disease and Inheritance
Paperback
RRP $29.99
$15.75
OFF
This product is categorised by
- Non-FictionScienceBiology, Life SciencesBiochemistry
- Non-FictionMedicineClinical & Internal MedicineNeurology & Clinical Neurophysiology
- Non-FictionMedicineNursing & Ancillary ServicesPharmacy & Dispensing
- Non-FictionMedicineOther Branches of MedicinePharmacology
- Non-FictionScienceBiology, Life SciencesMolecular Biology
- Non-FictionScienceBiology, Life SciencesCellular Biology
- Non-FictionScienceBiology, Life SciencesLife Sciences in GeneralNeurosciences























